Revvity | Devedores Comerciais





Devedores Comerciais Alterar Data
Agilent USD 1.52B 34M 2025-12
Align Technology USD 1.1B 2.38M 2025-12
Bio Techne USD 184.61M 717K 2025-12
Bio-Rad Laboratories USD 464.7M 5.2M 2025-09
Bruker USD 544.9M 6M 2025-12
Celltrion KRW 1.51T 128.69B 2025-09
Charles River Laboratories USD 1.43B 54.59M 2025-12
Cspc Pharmaceutical CNY 8.85B 769.12M 2025-06
Danaher USD 3.91B 762M 2025-12
Dentsply International USD 654M 8M 2025-09
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 5M 4.96M 2025-09
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Edwards Lifesciences USD 892.8M 9.8M 2025-09
Exact Sciences USD 306.05M 47.28M 2025-09
Hologic USD 584.2M 16.6M 2025-12
Illumina USD 854M 125M 2025-12
Intuitive Surgical USD 1.53B 267.6M 2025-12
IQVIA Holdings USD 3.43B 113M 2025-12
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Knight Therapeutics CAD 103M 8.1M 2024-09
Laboratorios Farma EUR 143.38M 16.93M 2023-12
Laboratory Of America USD 2.26B 4.5M 2025-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.65M 162K 2025-06
Mesa Laboratories USD 40.23M 4.66M 2024-09
Mettler Toledo International USD 778.24M 90.98M 2025-12
Myriad Genetics USD 118M 19M 2025-09
Neuren Pharmaceuticals AUD 20.71M 155.01M 2025-06
OraSure Technologies USD 38.1M 4.06M 2024-06
Organigram Holdings CAD 64.86M 7.31M 2025-09
Ovoca Bio EUR 447K 113K 2022-06
Pacific Biosciences Of California USD 29.38M 3.05M 2024-09
Pharma Mar EUR 41.76M 26.1M 2025-09
Qiagen NV USD 402.61M 9.05M 2025-12
Quest Diagnostics USD 1.41B 48M 2025-12
Quidel USD 417M 30.5M 2025-12
Repligen USD 158.59M 9.62M 2025-12
Revvity USD 744.67M 64.41M 2025-12
Sartorius EUR 344.7M 48.5M 2025-09
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Thermo Fisher Scientific USD 8.9B 11M 2025-12
Tilray USD 121.49M 18.12M 2025-03
Waters USD 828.84M 80.32M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09


Revvity Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.